Search results
Results from the WOW.Com Content Network
Serious side effects from the hepatitis B vaccine are very uncommon. [13] Pain may occur at the site of injection. [13] It is safe for use during pregnancy or while breastfeeding. [13] It has not been linked to Guillain–Barré syndrome. [13] Hepatitis B vaccines are produced with recombinant DNA techniques and contain immunologic adjuvant. [13]
World Hepatitis Day provides an opportunity to focus on actions such as: [1] Raising awareness of the different forms of hepatitis and how they are transmitted; Strengthening prevention, screening and control of viral hepatitis and its related diseases; Increasing hepatitis B vaccine coverage and integration into national immunization ...
DTwP-HepB-Hib vaccine is a 5-in-1 combination vaccine with five individual vaccines conjugated into one. [1] It protects against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type B, [1] which is generally used in middle- and low-income countries, where polio vaccine is given separately.
The Government Transformation Programme (GTP) is an effort by Malaysia's Government to address seven key areas concerning the people of the country. The programme was unveiled on 28 January, 2010, by Prime Minister Najib Razak, and is expected to contribute in making the country a developed and high-income nation as per its Vision 2020.
Malaysian national projects are major national projects that are important to the development of Malaysia. The following is a list from Malaysian independence in 1957 to the present. 1957–1963
Hepatitis B infection has been preventable by vaccination since 1982. [4] [12] As of 2022, the hepatitis B vaccine is between 98% and 100% effective in preventing infection. [1] The vaccine is administered in several doses; after an initial dose, two or three more vaccine doses are required at a later time for full effect. [1]
DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. [1]
For the medical community, the Hepatitis B Foundation organizes the International HBV Scientific Meeting annually for scientists discuss to new discoveries in hepatitis B research. [12] The organization is also actively involved in policy-making, helping ensure hepatitis B is a health priority at the local and federal level. [13] [14] [15]